Wells Fargo’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
Wells Fargo's BVS Position: Q3 2026 in Review
Wells Fargo reduced its Bioventus (BVS) stake by 67% in Q3 2026, selling an estimated $386K and leaving 14,646 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #4732.
Wells Fargo first reported a position in BVS in Q1 2021 and has held it in 23 quarters since. The position peaked at $2.63M in Q3 2021. 170 funds tracked by Wall St. Rank hold BVS as of Q3 2026.
- Wells Fargo held 14,646 shares of Bioventus worth $200K as of Q3 2026.
- Wells Fargo sold 29,318 Bioventus shares in Q3 2026, an estimated $386K.
- Bioventus made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #4732 holding.
- Wells Fargo first reported a position in Bioventus in Q1 2021 and has held it in 23 quarters since.
- Wells Fargo's Bioventus position peaked at $2.63M in Q3 2021.
- 170 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.